Opthea Ltd

ASX:OPT ISIN:AU000000OPT2

Opthea Limited, formerly Circadian Technologies Limited, is engaged in developing and commercializing therapies for cancer and eye diseases. The Company focuses on developing activities that covers targets, including vascular endothelial growth factors (VEGF-C, VEGF-D and VEGF receptor-3). It develops therapies for the treatment of diseases associated with blood and lymphatic vessel growth, such as angiogenesis, lymphangiogenesis and vascular leakage.

 
 
           

Lihat di Bahasa Lain

Berita

Laporan Pasar Australia 6 April 2011: Motopia Limited (ASX:MOT) Mendukung Layanan Online Business Wire Menjangkau Australia Dan Selandia Baru

🕔4/6/2011 12:00:56 PM 32215

Laporan Pasar Australia 6 April memuat: Anak Perusahaan Motopia Limited (ASX:MOT), yaitu cBox Pty Ltd telah ditunjuk sebagai mitra distribusi Australasia dari Business Wire; MACA Limited (ASX:MLD) memberikan layanan pemilihan dan pemecahan biji besi bagi WPG Resources Limited (ASX:WPG); Rey Resources Limited (ASX:REY) mengumumkan kenaikan Sumberdaya Terukur Batubara Termis pada Proyek Duchess Paradise; Circadian Technologies Limited (ASX:CIR) mengatakan bahwa VGX-100 secara signifikan menghambat pertumbuhan dan penyebaran berbagai jenis tumor pada manusia.

Baca Full Story
###

168,858 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 8) (30 Hari Terakhir: 38) (Sejak Ditampilkan: 12548) 

Data Perusahaan

    Fax
  • (03) 9824 0083 
  • Sektor Utama
  • Kesehatan & Pharm 
  • Industri Utama
  • Biotechnology 
  • Homepage
  • www.opthea.com.au

Lebih banyak Berita lagi

  • 2024/03/19: Opthea to Host Key Opinion Leader Event on April 3, 2024*
  • 2024/03/06: Opthea to Participate in Leerink Global Biopharma Conference*
  • 2024/03/04: Opthea Corporate Presentation - March 2024*
  • 2024/03/01: Change of Director's Interest Notice Update*
  • 2024/03/01: Change of Director's Interest Notice*
  • 2024/02/29: Opthea Reports Half-Year Results and Business Update*
  • 2024/02/29: Half Yearly Report and Accounts*
  • 2024/02/20: Opthea Appoints Arshard M Khanani as Chief Medical Advisor*
*refer to company website